Current approaches of nanomedicines in the market and various stage of clinical translation |
| |
Institution: | 1. State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China;2. Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264000, China;3. School of Pharmacy, University of Chinese Academy of Sciences, Beijing 100049, China;4. School of Pharmacy, University of Auckland, Auckland 1142, New Zealand |
| |
Abstract: | Compared with traditional drug therapy, nanomedicines exhibit intriguing biological features to increase therapeutic efficiency, reduce toxicity and achieve targeting delivery. This review provides a snapshot of nanomedicines that have been currently launched or in the clinical trials, which manifests a diversified trend in carrier types, applied indications and mechanisms of action. From the perspective of indications, this article presents an overview of the applications of nanomedicines involving the prevention, diagnosis and treatment of various diseases, which include cancer, infections, blood disorders, cardiovascular diseases, immuno-associated diseases and nervous system diseases, etc. Moreover, the review provides some considerations and perspectives in the research and development of nanomedicines to facilitate their translations in clinic. |
| |
Keywords: | Nanomedicines Nanoparticles Liposomes Vaccines Marketed products Clinical translations Disease-driven design Quality by design |
本文献已被 ScienceDirect 等数据库收录! |
|